Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amerise Biosciences Ltd has informed BSE that the trading window for dealing in its securities will remain closed from Thursday, 1st January 2026, until 48 hours after the declaration of Unaudited Financial Results for the quarter ended 31st December 2025. This is a standard compliance step taken under SEBI's Prohibition of Insider Trading Regulations, 2015, to prevent insiders from trading while they may have access to unpublished price-sensitive information. The date of the board meeting to consider the Q3 FY26 results will be communicated separately.
This is a routine regulatory filing with no direct impact on shareholders or the stock price. However, it signals that the company's Q3 (October–December 2025) financial results are expected soon, which investors should watch for as the next potential catalyst.